Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
No Longer Available No phase listed Expanded access

Expanded Access Program for Revumenib

ClinicalTrials.gov ID: NCT05918913

Public ClinicalTrials.gov record NCT05918913. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Expanded Access Program for SNDX-5613 in Patients With Relapsed/Refractory Acute Leukemias With Genetic Alterations Associated With HOXA Overexpression

Study identification

NCT ID
NCT05918913
Recruitment status
No Longer Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
Syndax Pharmaceuticals
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Revumenib Drug

Drug

Eligibility (public fields only)

Age range
6 Months and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Sep 4, 2025

United States locations

U.S. sites
35
U.S. states
21
U.S. cities
29
Facility City State ZIP Site status
Alabama Center for Childhood Cancer And Blood Disorders, Children's of Alabama Birmingham Alabama 35233
Phoenix Children's Hospital Phoenix Arizona 85016
City of Hope Duarte California 91010
City of Hope at Orange County Lennar Foundation Cancer Center Irvine California 92618
UCLA, UCLA RRMC, Drug Information Center, Department of Pharmaceutical Services Drug Supply Shipment Los Angeles California 90095
Lucile Packard Children's Hospital-Stanford Palo Alto California 94304
Rady Children's Hospital San Diego California 92123
University of California, San Francisco San Francisco California 94158
Center for Cancer and Blood Disorders, Colorado Children's Hospital Aurora Colorado 80045
HCTU, Division of Hematology, University of Colorado, Anschutz Medical Center Aurora Colorado 80045
Advent Health Orlando Orlando Florida 32804
Children's Healthcare of Atlanta Atlanta Georgia 30322
Winship Cancer Institute at Emory University Atlanta Georgia 30322
Lurie Children's Hospital of Chicago Chicago Illinois 60611
University of Chicago Medical Center Chicago Illinois 60637
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
Children's Hospital New Orleans Louisiana 70118
Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center Boston Massachusetts 02215
Children's Mercy Hospital-Kansas City Kansas City Missouri 64108
Siteman Cancer Center - Washington University St Louis Missouri 63110
Hackensack University Medical Center Hackensack New Jersey 07601
Memorial Sloan Kettering Cancer Center Long Island City New York 10065
Montefiore Medical Center The Bronx New York 10467
Duke University Medical Center Durham North Carolina 27705
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Division of Hematology and Oncology, Division of Pulmonary, Critical Care and Sleep Medicine, Vontz Center for Molecular Studies Cincinnati Ohio 45267
OSU Medical Center Columbus Ohio 43210
Doernbecher Children's Hospital, Oregon Health & Science University Portland Oregon 97239
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
St. Jude Children's Research Hospital Memphis Tennessee 38105
MD Anderson Cancer Center Houston Texas 77030
Memorial Hermann-Texas Medical Center Houston Texas 77030
Texas Children's Hospital Houston Texas 77030
Division of Hematology and Hematologic Malignancies, University of Utah-Huntsman Cancer Hospital Salt Lake City Utah 84112
Seattle Children's Research Institute, Seattle Childrens Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05918913, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05918913 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →